Synthesis and cancer antiproliferative activity of new histone deacetylase inhibitors: hydrophilic hydroxamates and 2-aminobenzamide-containing derivatives
Authors:
- T. MaedaTMT. Maeda
- Y. KawaiYKY. Kawai
- D. NakashimaDND. Nakashima
- T. OikawaTOT. Oikawa
- K. ShimokeKSK. Shimoke
- T. IkeuchiTIT. Ikeuchi
- H. KuwajimaHKH. Kuwajima
- S. UesatoSUS. Uesato
- 1 June 2006
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 41 (6) , 697-708
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or LymphomaJournal of Clinical Oncology, 2005
- Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying EnzymesAngewandte Chemie International Edition, 2005
- Histone deacetylase inhibitorsEuropean Journal of Medicinal Chemistry, 2005
- Potent histone deacetylase inhibitors: N-hydroxybenzamides with antitumor activitiesBioorganic & Medicinal Chemistry, 2004
- A sensitive and rapid liquid chromatography tandem mass spectrometry method for quantitative determination of 7‐ethyl‐10‐hydroxycamptothecin (SN‐38) in human plasma containing liposome‐based SN‐38 (LE‐SN38)Biomedical Chromatography, 2003
- NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myelomaBlood, 2003
- Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide DerivativesJournal of Medicinal Chemistry, 1999
- FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase InhibitorExperimental Cell Research, 1998
- What's Up and Down with Histone Deacetylation and Transcription?Cell, 1997
- Opening the Way to Gene ActivityScience, 1997